ControlPoint Inc
Solving Kennel Cough at the Point of Care
Solving Kennel Cough at the Point of Care
ControlPoint Inc is an innovative health care startup based in the United States, founded in 2020. The company's mission, as reflected in their slogan "Solving Kennel Cough at the Point of Care," is to improve animal health globally by offering efficient diagnostics solutions. Their flagship product is a pioneering single testing method for multiple pathogens, particularly relevant for diagnosing kennel cough, a common ailment that leads to millions of veterinarian visits annually. The ControlPoint test not only provides rapid in-clinic results, but also detects multiple respiratory pathogens, consequently enhancing patient care. The company has attracted a $256.00K grant investment from the esteemed National Science Foundation in 23 May 2022, affirming its potential to revolutionize animal diagnostics and the veterinary care industry. Overall, ControlPoint Inc's offering addresses a critical need in the market, promising both impactful solutions for veterinarians and sustainable revenue generation opportunities.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Grant | $256.00K | 1 |
|
23 May 2022 |
No recent news or press coverage available for ControlPoint Inc.
We care about your data, and we'd love to use cookies make your experience better.